Catalyst Wire Dossier Catalyst Wire Dossier

CEF

cyclophosphamide, epirubicin, and fluorouracil
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CEF, covering 2019-10-03 to 2019-10-03. Get the full timeline:

Most recent: Clinical Trial Update: 4 x Epirubicin, Cyclophosphamide, Followed by 4 x Docetaxel Versus 6 x CMF / 6 x CEF [Phase 3]

See pricing